4//SEC Filing
McCullough David 4
Accession 0001127602-09-005815
CIK 0000882796other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 2:56 PM ET
Size
5.5 KB
Accession
0001127602-09-005815
Insider Transaction Report
Form 4
Transactions
- Award
Emp. Stock Option (Right to Buy)
2009-03-02$1.20/sh+70,000$84,000→ 70,000 totalExercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]Options become exercisable at the rate of 25% after 1 year and then 1/48 per month thereafter until fully vested and exercisable after 48 months.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001395238
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 2:56 PM ET
- Size
- 5.5 KB